"Private practice rheumatology office with years of expertise diagnosing and treating patients. Our compassionate team pays attention to your needs and diligently works for approvals from your insurance company to get you the medications the doctor prescribes."

During the past decade, East Penn Rheumatology Associates, Pc conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 28 clinical trials were completed, i.e. on average, 186.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 17 clinical trials were completed. i.e. 425% of trials that started reached the finish line.

Out of the total clinical trials conducted in "East Penn Rheumatology Associates, Pc" #1 sponsor was "Pfizer" with 11 trials, followed by "Bristol-Myers Squibb" with 10 trials sponsored, "Eli Lilly and Company" with 6 trials sponsored, "CSL Behring" with 2 trials sponsored and "Genentech, Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "East Penn Rheumatology Associates, Pc" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Laboratory Corporation of America" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "East Penn Rheumatology Associates, Pc" are "Rheumatoid Arthritis" (14 trials), "Osteoarthritis" (4 trials), "Systemic Lupus Erythematosus" (4 trials), "Rheumatoid Arthritis (RA)" (3 trials) and "Arthritis" (2 trials). Many other conditions were trialed in "East Penn Rheumatology Associates, Pc" in a lesser frequency.

Most popular intervention types in "East Penn Rheumatology Associates, Pc" are "Drug" (33 trials), "Biological" (7 trials), "Other" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Methotrexate" (7 trials), "Baricitinib" (6 trials), "Abatacept" (4 trials) and "Adalimumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "East Penn Rheumatology Associates, Pc" are 39 trials for "All" genders.

Currently, there are NaN active trials in "East Penn Rheumatology Associates, Pc". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in East Penn Rheumatology Associates, Pc, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in East Penn Rheumatology Associates, Pc, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".